Mouse Anti-ALDH1L1 Recombinant Antibody (CBT4009) (V2LY-0625-LY1836)

Melzer, L., Freiman, T. M., & Derouiche, A. (2021). Rab6A as a pan-astrocytic marker in mouse and human brain, and comparison with other glial markers (GFAP, GS, Aldh1L1, SOX9). Cells, 10(1), 72.

Sharma, J., Krupenko, N. I., Pediaditakis, P., Helke, K., Strickland, K. C., & Krupenko, S. A. (2021). Effect ofALDH1L1folate enzyme on hepatocellular carcinoma inachemical carcinogenesismodel.

Michalovicz, L. T., Kelly, K. A., Vashishtha, S., Ben‐Hamo, R., Efroni, S., Miller, J. V., ... & O’Callaghan, J. P. (2019). Astrocyte‐specific transcriptome analysis using the ALDH1L1 bacTRAP mouse reveals novel biomarkers of astrogliosis in response to neurotoxicity. Journal of neurochemistry, 150(4), 420-440.

Krupenko, S. A., & Krupenko, N. I. (2019). Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression. Chemico-biological interactions, 302, 149-155.

Sukhorukova, E. G., Sufieva, D. A., & Korzhevskii, D. E. (2018). ALDEHYDE DEHYDROGENASE 1L1 IN RAT BRAIN CELLS. Medical academic journal, 18(1), 84-88.

Beniaminov, A. D., Puzanov, G. A., Krasnov, G. S., Kaluzhny, D. N., Kazubskaya, T. P., Braga, E. A., ... & Dmitriev, A. A. (2018). Deep sequencing revealed a cpg methylation pattern associated with aldh1l1 suppression in breast cancer. Frontiers in genetics, 9, 169.

Zhu, G., Liao, X., Han, C., Liu, X., Yu, L., Qin, W., ... & Peng, T. (2017). ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma. Oncology reports, 38(3), 1451-1463.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols